Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
NKE Nike Inc
ITG Investment Technology Group Inc
TAOIF TAG Oil Ltd
OTTR Otter Tail Corp
PZZA Papa John's International Inc
FGP Ferrellgas Partners LP
FUEL Rocket Fuel Inc
ARMK Aramark
BIP Brookfield Infrastructure Partners LP
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of unique ribonucleic acid (RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company is primarily focused on advancing the development of its potentially disease-modifying Duchenne Muscular Dystrophy (DMD) drug candidates, including its lead DMD product candidate, eteplirsen, which is an antisense PMO therapeutic in Phase III clinical development for the treatment of individuals with DMD who have an error in the gene coding for dystrophin that is amenable to skipping exon 51. The Company is also developing therapeutics using its technology for the treatment of drug-resistant bacteria and infectious, rare and other human diseases.

Closing Price
$33.81
Day's Change
0.28 (0.84%)
Bid
--
Ask
--
B/A Size
--
Day's High
34.46
Day's Low
32.29
Volume
(Light)
Volume:
1,185,492
10-day average volume:
1,730,527
1,185,492
  • Prev Close
    33.53
  • Today's Open
    33.50
  • Day's Range
    32.29-34.46
  • Avg Vol (10-day)
    1.7M
  • Last (time)
    4:00p ET 09/04/15
  • Last (size)
    19.0K
  • 52-Wk Range
    11.33 - 37.39
    LowHigh
  • (01/14/15 - 08/31/15)
    9.57%
  • 84.5%
  • Market Cap
    1.4B
  • Shares Outstanding
    41.5M
  • -4.29
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.3
  • 61.56
  • (% of float 08/15/15)
    35.79

Latest News

August 31, 2015
4:52 pm ET
BusinessWire
August 26, 2015
3:30 pm ET
Zacks
8:31 am ET
PR Newswire
August 25, 2015
5:17 pm ET
BusinessWire
August 21, 2015
8:30 am ET
BusinessWire
August 20, 2015
1:50 pm ET
Zacks
August 17, 2015
9:31 am ET
PR Newswire
August 12, 2015
8:30 am ET
BusinessWire
August 07, 2015
4:58 pm ET
Zacks
9:20 am ET
PR Newswire
August 06, 2015
7:00 am ET
BusinessWire
August 04, 2015
9:31 am ET
PR Newswire
July 31, 2015
5:15 pm ET
BusinessWire
July 30, 2015
8:30 am ET
BusinessWire
July 22, 2015
5:01 pm ET
BusinessWire
July 10, 2015
9:31 am ET
PR Newswire
July 07, 2015
3:55 pm ET
Zacks
July 02, 2015
8:30 am ET
Zacks
July 01, 2015
10:29 am ET
Zacks
8:30 am ET
BusinessWire
June 30, 2015
5:16 pm ET
BusinessWire
3:30 pm ET
Zacks
3:25 pm ET
Zacks
June 29, 2015
9:41 am ET
BusinessWire
7:01 am ET
BusinessWire
7:00 am ET
BusinessWire
June 26, 2015
5:35 pm ET
Zacks
June 24, 2015
9:31 am ET
PR Newswire
June 09, 2015
3:25 pm ET
Zacks
9:31 am ET
PR Newswire
May 19, 2015
5:52 pm ET
MarketWatch
May 06, 2015
8:26 am ET
MarketWatch
April 01, 2015
5:49 pm ET
MarketWatch
4:55 pm ET
MarketWatch
8:54 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2015 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Thomson Reuters; © Thomson Reuters Limited

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2015. All rights reserved.